Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Atkins

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 1, 1985
Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma: a preliminary analysisB L Powell, D V Jackson, C W Scarantino, et al.
Cancer Treatment Reports|July 1, 1985
Phase I study of high-dose cytarabine and cisplatin in patients with advanced malignancyJ N Atkins, H B Muss, R L Capizzi, et al.
Cancer|April 15, 1990
A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association StudyD R White, B L Powell, J B Craig, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignanciesB L Powell, H B Muss, R L Capizzi, et al.
Journal of the National Cancer Institute|December 9, 1997
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancerB Fisher, J Dignam, N Wolmark, et al.
Journal of Neuro-Oncology|January 1, 1986
Clinical trial of pyridoxine to reduce vincristine neurotoxicityD V Jackson, E K Pope, R A McMahan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association studyH B Muss, L D Case, J N Atkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04N Wolmark, H Rockette, E Mamounas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23B Fisher, S Anderson, E Tan-Chiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracilB Fisher, J Dignam, E P Mamounas, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|March 1, 1985
Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma: a preliminary analysisB L Powell, D V Jackson, C W Scarantino, et al.
Cancer Treatment Reports|July 1, 1985
Phase I study of high-dose cytarabine and cisplatin in patients with advanced malignancyJ N Atkins, H B Muss, R L Capizzi, et al.
Cancer|April 15, 1990
A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association StudyD R White, B L Powell, J B Craig, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignanciesB L Powell, H B Muss, R L Capizzi, et al.
Journal of the National Cancer Institute|December 9, 1997
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancerB Fisher, J Dignam, N Wolmark, et al.
Journal of Neuro-Oncology|January 1, 1986
Clinical trial of pyridoxine to reduce vincristine neurotoxicityD V Jackson, E K Pope, R A McMahan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association studyH B Muss, L D Case, J N Atkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04N Wolmark, H Rockette, E Mamounas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23B Fisher, S Anderson, E Tan-Chiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracilB Fisher, J Dignam, E P Mamounas, et al.
Pageof 4